Robert Andrew Douglas - 15 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol
RMD
Transactions as of
15 Nov 2022
Net transactions value
-$1,454,756
Form type
4
Filing time
16 Nov 2022, 16:40:03 UTC
Previous filing
15 Nov 2022
Next filing
18 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $66,627 +1,144 +3.4% $58.24 34,578 15 Nov 2022 Direct F1
transaction RMD ResMed Common Stock Options Exercise $983,557 +16,888 +49% $58.24 51,466 15 Nov 2022 Direct F1
transaction RMD ResMed Common Stock Sale $2,504,939 -11,280 -22% $222.07 40,186 15 Nov 2022 Direct F1, F2
holding RMD ResMed Common Stock 227,708 15 Nov 2022 Douglas Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -1,144 -6.3% $0.000000 16,888 15 Nov 2022 ResMed Common Stock 1,144 $58.24 Direct F3
transaction RMD ResMed Common Stock Options Options Exercise $0 -16,888 -100% $0.000000* 0 15 Nov 2022 ResMed Common Stock 16,888 $58.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 This transaction was executed in multiple trades at prices ranging from $221.77 $223.56. The price reported above reflects the weighted average sale price.
F3 Represents date options first became exercisable. Options vest 1/3 per year.